{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:40:51Z","timestamp":1761514851092,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T00:00:00Z","timestamp":1640563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T00:00:00Z","timestamp":1640563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["2018-7532"],"award-info":[{"award-number":["2018-7532"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s40744-021-00417-6","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T06:02:20Z","timestamp":1640584940000},"page":"509-520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patient Perspectives on Biologics for Axial Spondyloarthritis in a Cross-sectional Study in a Predominantly Female Population: Treatment Satisfaction, Wear-off Between Doses, and Use of Supplemental Medication"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4951-6476","authenticated-orcid":false,"given":"W. Benjamin","family":"Nowell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Gavigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J.","family":"Bolce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Lisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Himelein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchita","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica A.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,27]]},"reference":[{"issue":"2","key":"417_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/art.21619","volume":"54","author":"M Rudwaleit","year":"2006","unstructured":"Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum. 2006;54(2):569\u201378.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"417_CR2","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/ard.2008.101501","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, van der Heijde D, Landew\u00e9 R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009;68(6):784\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"417_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.mayocp.2016.12.008","volume":"92","author":"V Strand","year":"2017","unstructured":"Strand V, Singh JA. Evaluation and management of the patient with suspected inflammatory spine disease. Mayo Clin Proc. 2017;92(4):555\u201364.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"417_CR4","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/acr.21621","volume":"64","author":"JD Reveille","year":"2012","unstructured":"Reveille JD, Witter JP, Weisman MH. Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey. Arthritis Care Res (Hoboken). 2012;64(6):905\u201310.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"417_CR5","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/acr.24025","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, et al. 2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Care Res (Hoboken). 2019;71(10):1285\u201399.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"suppl 3","key":"417_CR6","doi-asserted-by":"publisher","first-page":"iii8","DOI":"10.1136\/ard.61.suppl_3.iii8","volume":"61","author":"J Sieper","year":"2002","unstructured":"Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002;61(suppl 3):iii8.","journal-title":"Ann Rheum Dis"},{"issue":"suppl_6","key":"417_CR7","doi-asserted-by":"publisher","first-page":"vi29","DOI":"10.1093\/rheumatology\/key200","volume":"57","author":"J Packham","year":"2018","unstructured":"Packham J. Optimizing outcomes for ankylosing spondylitis and axial spondyloarthritis patients: a holistic approach to care. Rheumatology. 2018;57(suppl_6):vi29\u201333.","journal-title":"Rheumatology"},{"issue":"11","key":"417_CR8","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1002\/art.11325","volume":"48","author":"JC Davis Jr","year":"2003","unstructured":"Davis JC Jr, Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, et al. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum. 2003;48(11):3230\u20136.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"417_CR9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/ard.2010.139261","volume":"70","author":"M Dougados","year":"2011","unstructured":"Dougados M, Braun J, Szanto S, Combe B, Elbaz M, Geher P, et al. Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE). Ann Rheum Dis. 2011;70(5):799\u2013804.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"417_CR10","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/art.38721","volume":"66","author":"M Dougados","year":"2014","unstructured":"Dougados M, van der Heijde D, Sieper J, Braun J, Maksymowych WP, Citera G, et al. Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 2014;66(8):2091\u2013102.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"417_CR11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/art.20852","volume":"52","author":"D van der Heijde","year":"2005","unstructured":"van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum. 2005;52(2):582\u201391.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"417_CR12","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1002\/art.21913","volume":"54","author":"D van der Heijde","year":"2006","unstructured":"van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2006;54(7):2136\u201346.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"417_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald O, Helliwell P, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis. 2014;73(1):6\u201316.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"417_CR14","doi-asserted-by":"publisher","first-page":"e028517-e","DOI":"10.1136\/bmjopen-2018-028517","volume":"9","author":"L Uhrenholt","year":"2019","unstructured":"Uhrenholt L, Schlemmer A, Hauge E-M, Christensen R, Dreyer L, Suarez-Almazor ME, et al. Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial). BMJ Open. 2019;9(7):e028517-e.","journal-title":"BMJ Open"},{"key":"417_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11365","author":"WB Nowell","year":"2021","unstructured":"Nowell WB, Gavigan K, Hunter T, Malatestinic WN, Bolce RJ, Lisse JR, Himelein C, Curtis JR, Walsh JA. Treatment satisfaction and decision-making from the patient perspective in axial spondyloarthritis: real-world data from a descriptive cross-sectional survey study from the arthritispower registry. ACR Open Rheumatol. 2021. https:\/\/doi.org\/10.1002\/acr2.11365.","journal-title":"ACR Open Rheumatology."},{"issue":"3","key":"417_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s10875-016-0243-z","volume":"36","author":"MA Rojavin","year":"2016","unstructured":"Rojavin MA, Hubsch A, Lawo JP. Quantitative evidence of wear-off effect at the end of the intravenous IgG (IVIG) dosing cycle in primary immunodeficiency. J Clin Immunol. 2016;36(3):210\u20139.","journal-title":"J Clin Immunol"},{"issue":"2","key":"417_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.rdc.2019.01.009","volume":"45","author":"WB Nowell","year":"2019","unstructured":"Nowell WB, Curtis D, Thai M, Wiedmeyer C, Gavigan K, Venkatachalam S, et al. Digital interventions to build a patient registry for rheumatology research. Rheum Dis Clin N Am. 2019;45(2):173\u201386.","journal-title":"Rheum Dis Clin N Am"},{"issue":"10 Suppl","key":"417_CR18","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1097\/MLR.0000000000000814","volume":"56","author":"WB Nowell","year":"2018","unstructured":"Nowell WB, Curtis JR, Crow-Hercher R. Patient governance in a patient-powered research network for adult rheumatologic conditions. Med Care. 2018;56(10 Suppl):S16\u201321.","journal-title":"Med Care"},{"issue":"12","key":"417_CR19","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21(12):2286\u201391.","journal-title":"J Rheumatol"},{"key":"417_CR20","unstructured":"Health NIo. Patient-Reported Outcomes Measurement Information System (PROMIS\u00ae). 2021. https:\/\/www.healthmeasures.net\/."},{"issue":"8","key":"417_CR21","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3899\/jrheum.190201","volume":"47","author":"MC Hwang","year":"2020","unstructured":"Hwang MC, Ogdie A, Puravath A, Reveille JD. Reliability and validity of patient-reported outcomes measurement information system short forms in ankylosing spondylitis. J Rheumatol. 2020;47(8):1182\u20138.","journal-title":"J Rheumatol"},{"issue":"1","key":"417_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s13075-018-1784-8","volume":"20","author":"L Law","year":"2018","unstructured":"Law L, Beckman Rehnman J, Deminger A, Klingberg E, Jacobsson LTH, Forsblad-d\u2019Elia H. Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex. Arthritis Res Ther. 2018;20(1):284.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"417_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s40744-019-0153-7","volume":"6","author":"A Ogdie","year":"2019","unstructured":"Ogdie A, Benjamin Nowell W, Reynolds R, Gavigan K, Venkatachalam S, de la Cruz M, et al. Real-world patient experience on the path to diagnosis of ankylosing spondylitis. Rheumatol Ther. 2019;6(2):255\u201367.","journal-title":"Rheumatol Ther"},{"issue":"5","key":"417_CR24","first-page":"748","volume":"37","author":"S D'Angelo","year":"2019","unstructured":"D\u2019Angelo S, Gilio M, D\u2019Attino RM, Gualberti G, Merolla R, di Luzio PU, et al. Observational study on the QUality of life of Italian Axial SpondyloARthritis patients (QUASAR): baseline data. Clin Exp Rheumatol. 2019;37(5):748\u201355.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"417_CR25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/rheumatology\/kex518","volume":"57","author":"MH Derakhshan","year":"2018","unstructured":"Derakhshan MH, Pathak H, Cook D, Dickinson S, Siebert S, Gaffney K, et al. Services for spondyloarthritis: a survey of patients and rheumatologists. Rheumatology. 2018;57(6):987\u201396.","journal-title":"Rheumatology"},{"issue":"5","key":"417_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11926-019-0819-8","volume":"21","author":"M Garrido-Cumbrera","year":"2019","unstructured":"Garrido-Cumbrera M, Poddubnyy D, Gossec L, G\u00e1lvez-Ruiz D, Bundy C, Mahapatra R, et al. The European map of axial spondyloarthritis: capturing the patient perspective\u2014an analysis of 2846 patients across 13 countries. Curr Rheumatol Rep. 2019;21(5):19.","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"417_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s40744-020-00208-5","volume":"7","author":"A Deodhar","year":"2020","unstructured":"Deodhar A, Sandoval D, Holdsworth E, Booth N, Hunter T. Use and switching of biologic therapy in patients with non-radiographic axial spondyloarthritis: a patient and provider survey in the United States. Rheumatol Ther. 2020;7(2):415\u201323.","journal-title":"Rheumatol Ther"},{"issue":"6","key":"417_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11926-018-0744-2","volume":"20","author":"T Rusman","year":"2018","unstructured":"Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE. Gender differences in axial spondyloarthritis: women are not so lucky. Curr Rheumatol Rep. 2018;20(6):35.","journal-title":"Curr Rheumatol Rep"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00417-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-021-00417-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00417-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:07:04Z","timestamp":1648555624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-021-00417-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,27]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1007\/s40744-021-00417-6","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"type":"print","value":"2198-6576"},{"type":"electronic","value":"2198-6584"}],"subject":[],"published":{"date-parts":[[2021,12,27]]},"assertion":[{"value":"17 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}